Medpace Holdings (MEDP) is a medical diagnostics and research firm that provides clinical development services to biotech, pharmaceutical, and medical device companies. The company is based in Cincinnati, Ohio and was founded in 1992. The stock price for Medpace has more than doubled in the last 14 months, but analysts and short-sellers are still pessimistic toward the stock. Medpace is set to report earnings on Monday, February 24 with a conference call to follow on Tuesday morning.
Analysts expect the company to report earnings of $0.75 per share for its fourth quarter